Global Non-Invasive Prenatal Testing (NIPT) Market 2020-2031: Focus on Method, Test, Platform, End-user, Application and Country - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The \"Global Non-Invasive BGI prenatal test Market: Focus on Method, Test, Platform, End User, Application and Country Analysis and Forecast, 2020-2031\" report has been added to ResearchAndMarkets.com\'s offering.

The global NIPT market was valued at $2.52 billion in 2020 and is expected to reach $12.61 billion by 2031, registering a CAGR of 15.79% during the forecast period 2021-2031.

Market Dynamics

Growth Drivers

Increased Emphasis on Early Detection and Prevention

Availability of Advanced Screening Technologies

Increasing Consumer Demand

Shifting of Reimbursement Policies Toward More Genetics Coverage

High Incidence Rate of Down\'s Syndrome

Rising Average Maternal Age

Increasing Prevalence of Genetic and Congenital Disorders

Challenges

Stringent Regulatory Guidelines and Ethical Hurdles

Limitations of NIPT

Lack of Awareness Among Consumers

Alternative Screening and Testing Methods

Opportunities

Capitalizing on the Potential Presented by the Emerging Markets in Asia

Availability of Direct-to-Consumer Tests

Focus on Pre-Implantation Genetic Diagnosis

Market Segmentation

By Test - Panorama and Vistara; MaterniT GENOME, MaterniT 21 PLUS, informaSeq, Verifi and Verifi Plus Prenatal Tests; Harmony Test; NIFTY Test and NIFTY Test Pro; QNatal Advanced; PrenaTest, GeneSafe, and PrenatalSAFE; Bambni Test; IONA and Sage; and Others.